Relevance of Pioglitazone in Indian T2DM Care Continuum Dr. Vijay Panikar27 May 2025 11:30 AM ISTIndia is experiencing a rising burden of type 2 diabetes (T2D), affecting 11.4% of adults. Hypertension (35.5%), generalized obesity (28.6%),...
Azmarda Outperforms Generic Sacubitril/Valsartan in HFrEF Management, says new study Dr. Garima Soni22 May 2025 11:30 AM ISTAhmedabad: Azmarda, an innovator brand of Sacubitril/Valsartan, demonstrated superior efficacy compared to generic Sacubitril/Valsartan in patients...
Re-visiting the Role of Pneumococcal Vaccination in Patients with Cardiovascular Diseases Dr. Sanjay Mittal14 May 2025 11:37 AM ISTCardiovascular diseases (CVD) account for 24.8% of all deaths in India, with an age-standardized death rate of 272 per 100,000-higher than the global...
Prediabetes and the Mind: Unraveling Cognitive and Mental Health Risks Dr. Yalamanchi Amulya13 May 2025 9:00 AM ISTPrediabetes is a clinical precursor not only to diabetes but also to emerging cognitive impairment and neuropsychiatric symptoms. In a cohort of...
Aspirin in Primary Prevention- When to Consider? Dr A B Chandorkar9 May 2025 11:16 AM ISTReframing Aspirin's Role in Primary Prevention: Evolving evidence has refined our understanding of aspirin's role in primary prevention. While earlier...
Aspirin Use in Women Aged 40-50 with Diabetes and Hypertension: Identifying the Ideal Candidates Dr. Salil Vaidya28 April 2025 10:25 AM ISTCVD Risk in Women After 40: Cardiovascular disease (CVD) is the leading cause of death in individuals with type 2 diabetes (T2D) and hypertension. (1)...
Prediabetes and CV Risk: Evidence Review in 2025 Dr.Soumya S L11 April 2025 12:30 PM ISTPrediabetes: Potential Cardiovascular (CV) Warning Sign: India has a high prediabetes prevalence (15.3%), nearly equal in urban (15.4%) and rural...
Dapagliflozin Sitagliptin-Preferred SGLT2i-DPP4i FDC in Indian Clinical Practice Dr. Saptarshi Bhattacharya7 April 2025 11:34 AM ISTType 2 diabetes mellitus (T2DM) is a major public health challenge in India, with an estimated 101 million individuals affected and 39.4 million...
Indian CV Risk Factors and Emerging Evidence for Aspirin in Primary Prevention- What's New? Dr. Jay Shah5 April 2025 11:32 AM ISTCardiovascular diseases (CVDs) remain the leading cause of mortality and disability in India, contributing to 31.8% of deaths. Noncommunicable...
Association of Physicians of India Consensus Recommendations for Vonoprazan in Management of Acid Peptic Disorders Dr. Kamal Kant Kohli26 March 2025 11:36 AM ISTThe Association of Physicians of India (API) has recently issued a consensus statement, highlighting vonoprazan as an effective option for managing...
Brief Review on Vitamin D Formulations: Spotlight on Nanoemulsion and Its Innovations Dr. Kamal Kant Kohli18 March 2025 10:52 AM ISTDeficiency and insufficiency of vitamin D is a global concern, affecting a vast proportion of the Indian population as well; with reportedly 85%...
Prediabetes and Associated Risk in Young Adults - Alopecia Areata and Erectile Dysfunction Dr Anshul Agrawal13 March 2025 12:23 PM ISTThe rising prevalence of prediabetes among young adults signals early metabolic dysfunction, significantly increasing the risk of type 2 diabetes...
